These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20655918)

  • 1. Cushing's syndrome, glucocorticoids and the kidney.
    Smets P; Meyer E; Maddens B; Daminet S
    Gen Comp Endocrinol; 2010 Oct; 169(1):1-10. PubMed ID: 20655918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in Cushing's syndrome.
    Magiakou MA; Smyrnaki P; Chrousos GP
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):467-82. PubMed ID: 16980206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cushing's syndrome of nonpituitary causes.
    Carroll TB; Findling JW
    Curr Opin Endocrinol Diabetes Obes; 2009 Aug; 16(4):308-15. PubMed ID: 19491665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between thyroid and kidney function in pathological conditions of these organ systems: a review.
    van Hoek I; Daminet S
    Gen Comp Endocrinol; 2009 Feb; 160(3):205-15. PubMed ID: 19133263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of dyslipidemia in Cushing's syndrome.
    Arnaldi G; Scandali VM; Trementino L; Cardinaletti M; Appolloni G; Boscaro M
    Neuroendocrinology; 2010; 92 Suppl 1():86-90. PubMed ID: 20829625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercortisolism affects glomerular and tubular function in dogs.
    Smets PM; Lefebvre HP; Kooistra HS; Meyer E; Croubels S; Maddens BE; Vandenabeele S; Saunders JH; Daminet S
    Vet J; 2012 Jun; 192(3):532-4. PubMed ID: 21723755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid action and the clinical features of Cushing's syndrome.
    Yanovski JA; Cutler GB
    Endocrinol Metab Clin North Am; 1994 Sep; 23(3):487-509. PubMed ID: 7805650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior chronic in vivo glucocorticoid excess leads to an anabolic phenotype and an extension of cellular life span of skin fibroblasts in vitro.
    Kletsas D; Pratsinis H; Gioni V; Pilichos K; Yiacoumettis AM; Tsagarakis S
    Ann N Y Acad Sci; 2007 Apr; 1100():449-54. PubMed ID: 17460210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cushing's syndrome.
    Shibli-Rahhal A; Van Beek M; Schlechte JA
    Clin Dermatol; 2006; 24(4):260-5. PubMed ID: 16828407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of antenatally or postnatally administered steroids.
    Cattarelli D; Chirico G; Simeoni U
    Pediatr Med Chir; 2002; 24(2):157-62. PubMed ID: 11987524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of diabetes mellitus in Cushing's syndrome.
    Munir A; Newell-Price J
    Neuroendocrinology; 2010; 92 Suppl 1():82-5. PubMed ID: 20829624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal effects of felodipine--a review.
    Elmfeldt D; Nordlander M; Edgar B
    Kidney Int Suppl; 1992 May; 36():S54-60. PubMed ID: 1614069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and treatment of Cushing's syndrome.
    Nieman LK; Ilias I
    Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In what clinical settings should Cushing's syndrome be suspected?
    Bruno OD; Juárez-Allen L; Rossi MA; Longobardi V
    Medicina (B Aires); 2009; 69(6):674-80. PubMed ID: 20053613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of selected angiogenesis-related small microRNAs in patients with abnormally increased secretion of glucocorticoids.
    Kawa MP; Sobuś A; Litwińska Z; Osowicz-Korolonek L; Cymbaluk-Płoska A; Stecewicz I; Zagrodnik E; Romanowska H; Walczak M; Syrenicz A; Machaliński B
    Endokrynol Pol; 2019; 70(6):489-495. PubMed ID: 31909455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of Cushing's disease.
    Fehm HL; Voigt KH
    Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficits in hippocampus-mediated Pavlovian conditioning in endogenous hypercortisolism.
    Grillon C; Smith K; Haynos A; Nieman LK
    Biol Psychiatry; 2004 Dec; 56(11):837-43. PubMed ID: 15576060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should we evaluate for cardiovascular disease in patients with Cushing's syndrome?
    Fallo F; Sonino N
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):768-71. PubMed ID: 19508589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.